GPR35 and cancer: In CRC cells, GPR35 inhibits YAP/TAZ phosphorylation, thereby enhancing YAP/TAZ transcriptional activity and promoting anchorage-independent growth of cancer cells, while small molecule inhibitors CID-2745687 and ML145 can effectively block this pathway (56).